Evidence map›Paper›PMID 33572271›Full record

ReviewToxins2021

Structural Basis of the Pore-Forming Toxin/Membrane Interaction.

Yajuan Li, Yuelong Li, Hylemariam Mihiretie Mengist, Cuixiao Shi, Caiying Zhang, Bo Wang, Tingting Li, Ying Huang, Yuanhong Xu, Tengchuan Jin

Open access · goldAbstract readReview
In one paragraph

Review in Toxins, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 45 citations in OpenAlex.

  1. Step-by-step maturation mechanism of the binary toxin pore revealed by cryo-EM analysis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yajuan LiDepartment of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
Yuelong LiHefei National Laboratory for Physical Sciences at Microscale, Laboratory of Structural Immunology, CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, School of Basic Medical Sciences, University of Science and Technology of China, Hefei 230027, China.
Hylemariam Mihiretie MengistHefei National Laboratory for Physical Sciences at Microscale, Laboratory of Structural Immunology, CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, School of Basic Medical Sciences, University of Science and Technology of China, Hefei 230027, China.
Cuixiao ShiDepartment of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
Caiying ZhangHefei National Laboratory for Physical Sciences at Microscale, Laboratory of Structural Immunology, CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, School of Basic Medical Sciences, University of Science and Technology of China, Hefei 230027, China.
Bo WangDepartment of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
Tingting LiDepartment of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
Ying HuangDepartment of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
Yuanhong XuDepartment of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
Tengchuan JinHefei National Laboratory for Physical Sciences at Microscale, Laboratory of Structural Immunology, CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, School of Basic Medical Sciences, University of Science and Technology of China, Hefei 230027, China.ORCID 0000-0002-1395-188X
Anhui Medical University · CNUniversity of Science and Technology of China · CN

Funding

the Emergency Research and Public Relations Project of Anhui Medical University YJGG202002the National Natural Science Foundation of China 31870731the National Natural Science Foundation of China 31971129the Strategic Priority Research Program of the Chinese Academy of Sciences XDB29030104
6 · The paper itself

Abstract

With the rapid growth of antibiotic-resistant bacteria, it is urgent to develop alternative therapeutic strategies. Pore-forming toxins (PFTs) belong to the largest family of virulence factors of many pathogenic bacteria and constitute the most characterized classes of pore-forming proteins (PFPs). Recent studies revealed the structural basis of several PFTs, both as soluble monomers, and transmembrane oligomers. Upon interacting with host cells, the soluble monomer of bacterial PFTs assembles into transmembrane oligomeric complexes that insert into membranes and affect target cell-membrane permeability, leading to diverse cellular responses and outcomes. Herein we have reviewed the structural basis of pore formation and interaction of PFTs with the host cell membrane, which could add valuable contributions in comprehensive understanding of PFTs and searching for novel therapeutic strategies targeting PFTs and interaction with host receptors in the fight of bacterial antibiotic-resistance.

Indexed as

AnimalsAnti-Bacterial AgentsBacteriaBacterial ProteinsBacterial ToxinsCell MembraneDrug ResistanceHost-Pathogen InteractionsHumansMolecular Targeted TherapyPore Forming Cytotoxic ProteinsProtein ConformationStructure-Activity RelationshipVirulenceAnti-Bacterial AgentsBacterial ProteinsBacterial ToxinsPore Forming Cytotoxic Proteinsmembrane interactionpore-forming toxinstructure

Identifiers

PMID33572271
PMCPMC7914777
OpenAlexW3128574471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.